The site management organization market is estimated to grow from USD 12.4 billion in the current year to USD 31. 6 billion by 2035, at a CAGR of 9.8% during the forecast period, till 2035.
Additionally, due to the intrinsic complexity of the entire process and the participation of multiple stakeholders, these trials are susceptible to delays. Over 80% of clinical trials experience delays ranging from one to six months, whereas merely 10% of the studies finish on schedule. Consequently, innovators within the pharmaceutical sector are consistently working on enhancing methods for executing clinical trials and managing them effectively. Among other options, delegating different trial operations to a dedicated service provider, such as site management organizations (SMOs), has become a prominent choice for many developers. As the complexity increases and the number of registered clinical trials rises, the need for SMOs is expected to see consistent market growth throughout the forecast period.
In the current year, North America captures the majority share of the overall clinical trial site management market and this trend is unlikely to change in the foreseen future. However, Asia-Pacific is likely to grow at a faster growth rate, with a CAGR of 13.7% during the forecast period.
SITE MANAGEMENT ORGANIZATIONS MARKET: GROWTH AND TRENDS
Clinical trials are a crucial step of the entire drug development process, allowing for the essential assessment of a drug candidate's safety and effectiveness. Research indicates that approximately 40% of the overall investment allocated for the advancement of drug candidates is spent on clinical trials, amounting to an annual cost of USD 78 billion. Nonetheless, conducting such trials frequently presents significant difficulties, including scientific and operational intricacies, challenges with recruitment and retention of appropriate patients, challenges associated with data management, and rigorous regulatory standards.Additionally, due to the intrinsic complexity of the entire process and the participation of multiple stakeholders, these trials are susceptible to delays. Over 80% of clinical trials experience delays ranging from one to six months, whereas merely 10% of the studies finish on schedule. Consequently, innovators within the pharmaceutical sector are consistently working on enhancing methods for executing clinical trials and managing them effectively. Among other options, delegating different trial operations to a dedicated service provider, such as site management organizations (SMOs), has become a prominent choice for many developers. As the complexity increases and the number of registered clinical trials rises, the need for SMOs is expected to see consistent market growth throughout the forecast period.
Market Growth Drivers
The site management organization (SMO) market is driven by increasing clinical trial volume and complexity, as registered studies require specialized site assistance for Phase II / III and precision medicine. Moreover, the increasing prevalence of chronic and rare diseases drives the need for SMOs' expertise in patient recruitment and retention via EHRs and community networks. The transition to decentralized and hybrid trials boosts SMO implementation for overseeing remote monitoring, digital resources, and data accuracy. Further, trends in outsourcing, growth of emerging markets in Asia-Pacific and LATAM, along with technology integration such as AI and eConsent propel further expansion. It is worth highlighting that the need for real-world evidence and post-marketing research is transforming SMOs into scalable, high-value networks.Market Restraints
The Site Management Organization (SMO) market faces considerable limitations due to high operational expenses, such as employee training, adherence to regulations, and technology integration which present competitive pricing challenges. Severe rivalry from internal site networks, major CROs with incorporated SMOs, and rising integrated research organizations (IROs) hampers market share and compels smaller SMOs to focus on niche sectors. Recruitment and retention of patients continue to pose challenges, leading to considerable trial delays from insufficient enrollment, even with SMO initiatives. Ultimately, reliance on CRO-sponsor agreements and economic fluctuations in emerging markets subject SMOs to revenue unpredictability, thus hindering their market expansion.SITE MANAGEMENT ORGANIZATIONS MARKET: KEY INSIGHTS
The report delves into the current state of the site management organizations market and identifies potential growth opportunities within industry. Some key findings from the report include:
- Presently, around 250 players across the globe claim to offer clinical trial site management services to trial sponsors, for both therapeutic products and medical devices.
- The market is fragmented, featuring the presence of both established players and new entrants based in different geographies that claim to be capable of offering site management services, for wide range of therapeutic areas.
- Companies involved in this domain are steadily expanding their capabilities in order to enhance their respective service portfolios and comply to evolving industry benchmarks.
- Over 200 deals have been inked in the past five years; majority of the reported collaborations were focused on forming service alliances and clinical trial agreements to offer clinical research services to sponsors.
- Foreseeing a lucrative future, a large number of investors have invested capital worth USD 1 billion, across 29 instances, in companies offering clinical trial site management services.
- In 2020, around 10,000 trials were registered to evaluate various types of potential interventions and develop evidence-based medicine and health care solutions, worldwide.
- There has been a surge in the demand for study participants owing to the continuous growth in number of clinical trials; this has prompted drug developers to leverage services to third party service providers.
- With more than 60% of the clinical trial operations currently being outsourced, we expect the market to grow at a steady pace over the next decade.
- The anticipated opportunity is expected to be segregated across a variety of therapeutic areas; it is also likely to be well-distributed across key geographical regions.
Site Management Organization Market
The market sizing and opportunity analysis has been segmented across the following parameters:
Therapeutic Areas
- Oncological Disorders
- CNS Disorders
- Infectious Diseases
- Cardiovascular Diseases
- Others
Trial Phases
- Phase I
- Phase II
- Phase III
- Phase IV
Clinical Trial Components
- Site Management
- Onsite monitoring
- Project Management
- Others
Type of Interventions
- Therapeutics
- Devices
- Surgical Procedures
Key Geographies
- North America
- Europe
- Rest of the World
SITE MANAGEMENT ORGANIZATIONS MARKET: KEY SEGMENTS
SMOs Market is Likely to be Dominated by Trial Studies Intended for the Treatment / Management of Oncological Indications
In terms of therapeutic area, the market is segmented across oncological disorders, CNS disorders, infectious diseases, respiratory disorders, cardiovascular diseases, endocrine disorders, gastrointestinal disorders, musculoskeletal diseases, immunological disorders, dermatological disorders and others. The SMOs market is likely to be dominated by trial studies intended for the treatment / management of oncological indications, capturing 38% of the market share by 2035. This is owing to an increase in number of trials currently being / anticipated to be conducted to investigate the potential of drugs targeting oncological indications, worldwide.SMOs market for Phase II Trial Studies is Likely to Dominate during the Forecast Period
In terms of the trial phase, the overall market is segmented across Phase I, Phase II, Phase III and Phase IV. The SMOs market for phase II trial studies is likely to capture nearly 40% of the market share in the current year, growing at a CAGR of 12.1%, during the given time periodSite Management Activities is Anticipated to Lead the Site Management Organization Market during the Forecast Period
In terms of clinical trial operations, the overall market is segmented across site management, data management, quality control, onsite manufacturing, regulatory affairs, project management, logistics and others. The SMOs market for site management activities (including site identification and selection, site contracting and payments, site initiation and activation and site close-out) is likely to capture around 30% of the market share in the current year, growing at a CAGR of 9.8%, during the given forecast period.Market For Therapeutics (Drugs and Biologics) is Likely to Grow at a CAGR of 9.8%, During the Given Time Period
In terms of therapeutics, the overall market is segmented across surgical procedures, devices and therapeutics. the SMOs market for therapeutics (drugs and biologics) is likely to be worth USD 22 billion in 2035, growing at a CAGR of 9.8%, during the given time period.North America is Likely to Propel the Growth of the Site Management Organization Market
In terms of geographical regions, the overall market is segmented across North America, Europe, Asia-Pacific, Latin America, MENA and RoW.In the current year, North America captures the majority share of the overall clinical trial site management market and this trend is unlikely to change in the foreseen future. However, Asia-Pacific is likely to grow at a faster growth rate, with a CAGR of 13.7% during the forecast period.
Recent Developments in Site Management Organization Market:
Several recent developments have taken place in the field of site management organization. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.- Psyence Biomed entered into a strategic agreement with Australian Clinical Trial Network (ACTioN) for its Phase IIb clinical trial.
- Flourish Research received strategic investment from Genstar Capital to further expand its clinical research services.
- Neutra Corporation acquired Mercury Clinical Research, a US based site management organization. Blackstone, an asset management company, also announced its plans to acquire Tokyo based SMO I’rom Group.
Primary Research Overview
The opinions and insights presented in the market report were also influenced by discussions held with senior stakeholders in the industry. The market research report features detailed transcripts of interviews held with the following individuals:- Country Head - Clinical Operations, Mid-sized Company, India
- Medical Director and Operations Manager, Small Company, Argentina
- Project Manager, Small Company, India
Example Players in Site Management Organizations Market
- FOMAT Medical Research
- Parexel
- Pharm-Olam
- Veristat
- WCCT Global
- Worldwide Clinical Trials
- CROMSOURCE
- Fidelis Research
- Scandinavian CRO
- TFS HealthScience
- Trialbee
- CMIC Group
- George Clinical
- Tigermed
- Veeda Clinical Research
SITE MANAGEMENT ORGANIZATIONS MARKET: RESEARCH COVERAGE
- Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the site management organizations market, focusing on key market segments, including [A] therapeutic area, [B] trial phases, [C] clinical trial components, [D] type of interventions, and [E] key geographical regions.
- Market Landscape: A detailed assessment of overall competitive landscape companies offering clinical trial management services to various organizations, including CROs, and pharmaceutical, biotechnology and medical devices companies based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of service offered, and [E] therapeutic expertise of service providers.
- Company Competitiveness Analysis: A comprehensive competitive analysis of service providers segregated into three peer groups based on location of their headquarters (North America, Europe, and Asia-Pacific and RoW), examining factors, such as [A] supplier strength [B] product strength and [C] application areas.
- Company Profiles: In-depth profiles of prominent players that offer various SMO services focusing on [A] year of establishment, [B] location of headquarters, [C] product portfolio, [D] recent developments and [E] an informed future outlook.
- Partnerships and Collaborations: An analysis of the partnerships that have been inked by stakeholders engaged in site management organization market, based on various parameters, such as [A] year of partnership, [B] type of partnership, [C] focus area and [D] most active players.
- Funding and Investment Analysis: A detailed analysis of various investments received by players engaged in site management organization market based on several relevant parameters, such as [A] year of investment, [B] number of funding instances, [C] amount invested, [D] type of funding (grant, seed, venture capital, secondary offering, other equity, debt and others) and [E] type of investor, [F] most active players, [G] most active investors and [H] geographical distribution (in terms of number of funding instances and amount invested).
- Clinical Trial Analysis: An in-depth analysis of completed, ongoing and planned clinical studies based on several relevant parameters, such as [A] trial registration year, [B] number of enrolled patients, [C] trial status, [D] trial phase, [E] type of sponsor and [F] geographical distribution of number of trials and enrolled patient population.
- Demand Analysis: An analysis of the annual demand for clinical study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players.
KEY QUESTIONS ANSWERED IN THIS REPORT
- What is a site-specific management organization and how does it operate?
- How many companies are currently engaged in this market?
- Which are the leading companies in this market?
- Which region dominates the site management organizations market?
- What are the key trends observed in the site management organizations market?
- What factors are likely to influence the evolution of this market?
- What are the primary challenges faced by site management organizations?
- What is the current and future market size?
- What is the CAGR of this market?
- How is the current and future market opportunity likely to be distributed across key market segments?
REASONS TO BUY THIS REPORT
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
- Complimentary PPT Insights Packs
- Complimentary Excel Data Packs Covering All Analytical Modules
- Up to 15% Complimentary Content Customization
- In-Depth Report Walkthrough with the Research Team
- Complimentary Report Update if the Report is 6+ Months Old
Table of Contents
1. PREFACE
3. INTRODUCTION
4. COMPETITIVE LANDSCAPE
5. COMPANY COMPETITIVENESS ANALYSIS
6. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN NORTH AMERICA
7. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN EUROPE
8. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN ASIA-PACIFIC
9. PARTNERSHIPS AND COLLABORATIONS
10. FUNDING AND INVESTMENT ANALYSIS
11. KEY INSIGHTS FROM CLINICAL TRIAL ANALYSIS
12. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS
13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
15. EXECUTIVE INSIGHTS
LIST OF FIGURES
LIST OF TABLES
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3H Medi Solution
- 3S Pharma
- Accel Clinical Services
- Accell Clinical Research
- Accelovance
- accerise
- Access Clinical Research
- Ace Research
- ACI Clinical
- Acrostar SMO
- ACTG-CRO
- Advanced Clinical
- Aetion
- Affiliated Clinical Research
- AiCure
- Alpha Oncology Research (AOR)
- Altasciences
- Amadeus Capital Partners
- AmberCRO
- American Liver Foundation
- American Research Associates (ARA)
- AmerisourceBergen
- Analgesic Solutions
- Andronovo Labs
- Anteris Bio
- Antev
- Antidote
- AOBiome Therapeutics
- Apex Medical Research
- APF Research
- ApotheCom
- Apptomics
- Aptitude Health
- Ardent Clinical Research Services
- Asian Eye Institute
- Associated Medical
- Association of Clinical Research Professionals (ACRP)
- AstraZeneca
- Atlant Clinical
- Aurum Clinical Research
- AusTrials
- AutoCruitment
- Avacare
- AXELLE Group
- AXIM Biotechnologies
- BBK Worldwide
- Beijing Aisimo Medical Science and Technology
- Beijing CTSMED
- Beijing EasyTrial MedTech
- Beijing Global Pharmaceutical Research (Acquired by EPS International)
- Beijing Illness Challenge Foundation (ICF)
- Best Clinical Practice
- Bioclinica
- Biomapas
- Biomedical Advanced Research and Development Authority (BARDA)
- Biomic Lifescience
- Biosite Research
- Box
- BrainStorm Cell Therapeutics
- Briban Invest
- Bridge Clinical Research
- BTC Network
- Cactus Clinical Research
- Calmark
- Canadian Centre for Clinical Trials (CCCT)
- Cardialysis
- CaringKind
- Caris Life Sciences
- Carpathian Research
- Catalyst Regulatory Services (Acquired by Veristat)
- CCT Research
- Central India Clinical Research Services (CICRS)
- Centre International de Développement Pharmaceutique (CIDP)
- Chase Medical Research
- ChiG
- Chrondel
- Cidara Therapeutics
- Cinven
- Clariness
- Cliantha Research
- Clin Sol
- CLINADE
- Clinart MENA
- ClinChoice
- ClinEdge
- Clinerion
- Clinexa Life Sciences
- Clinical Accelerator
- Clinical Development Solutions (CDS)
- Clinical Endpoints
- Clinical Investigation Centre (University Malaya Medical Centre)
- Clinical Research Fastrack
- Clinical Research Partners
- Clinical Trial Networking (CT-N)
- Clinical Trials Management Solutions (CTMS)
- ClinicalConnection
- Clinipace
- CLINISYD
- Clinixir
- ClinROtech
- ClinSmart
- Clinsol
- Clinspire Research
- Clintec
- Clintract
- ClinVax
- Clinverse
- ClinWin Research Services
- CLS-Ukraine
- CluePoints
- CMIC Group
- CMX Research
- CNS Pharmaceuticals
- COD Research
- Comac Medical
- COMPASS Pathways
- Compass Research
- Continuum Clinical
- Cosmic Clinical Services
- Credevo
- Crestline Investors
- CRO Pharmatrendz
- Croissance Clinical Research
- CROMSOURCE
- CRS Clinical Research Services
- CTC North
- CTI Clinical Trial and Consulting Services
- CTM
- CX Partners
- Cyclo Therapeutics
- Cytespace
- DAC Patient Recruitment Services
- Datavant
- DAVA Oncology
- DaVita Clinical Research
- Deep Lens
- Deerfield Management
- DEMEDICA
- Devana Solutions
- DFnet
- Dimension Research
- Direct Biologics
- dMed
- Duke Clinical Research Institute (DCRI)
- eClinical Solutions
- Edenwell Therapeutics
- EDETEK
- Effectus CTR
- EGeen
- Elligo Health Research
- EMMES
- emovis
- Empower Capital
- EPS Associates
- EPS International
- EQT
- ERT
- ESTERN Medical
- Estudios Clínicos Latinoamérica (ECLA)
- Ethicscare Clinical Research Services (ECRS)
- EthosExcel
- Everest Clinical Research
- Evolution Research Group (ERG)
- Experior
- F2 Ventures
- FARMEPO
- FDAMap
- Febo
- FedDev Ontario
- FHI Clinical
- Fidelis Research
- FOMAT Medical Research
- Foundation Medicine
- Free to Breathe
- Frenova Renal Research
- Fresenius Medical Care
- Gaea
- Gama CRO
- GB Sciences
- GCP Clinical Studies
- GCP Research
- G-CURE Healthcare
- GDD Experts
- Genentech
- General Atlantic
- George Clinical
- GIC
- Global Clinical Trials
- Goldman Sachs Asset Management International (GSAMI)
- Gratisol Labs
- GSK
- GuideStar Research
- Haihe Biopharma
- Hatteras Venture Partners
- Haxon Life Sciences
- Healing Hands Clinical Research Services (HHCRS)
- HealthVerity
- Horizon Research
- Hospital Alemão Oswaldo Cruz
- EI Hospital de Especialidades Teodoro Maldonado Carbo
- Hoth Therapeutics
- hyperCORE International
- I’rom Group
- iCo Therapeutics
- iDD Research Solutions
- IKCON PHARMA
- Illingworth Research Group
- InClin
- Incred CR
- Indian Institute of Clinical Research & Management (IICRM)
- Industrifonden
- Infectious Disease Research Institute (IDRI)
- InformedDNA
- Innoplexus
- Innovaderm
- Innovate Research
- Insignia Clinical Services (ICS)
- INSPIRE
- Integrity Capital Wealth Management
- Inteliquet
- International Research Networks (IRN)
- Intouch Clinical Research Center
- Intrinsic Imaging (Acquired by WCG)
- Invicro
- IPHARMA
- IQVIA
- ITOCHU
- ITOCHU Technology Ventures
- Johnson Clinical Research
- Juno Research
- Karyopharm Therapeutics
- Klinar CRO
- KlinEra
- KMR Group
- Komplett Clinical Research (KCR)
- KPS Clinical Services
- KV Clinical Research Services (KVCR)
- Kyung Hee University Hospital
- LEADS Clinical Research and Bio Services
- Limbix
- Linical Americas
- Link Health
- LITMUS
- LiveRamp
- LMC Manna Research
- Lyft
- MakroCare
- Marshfield Clinic Research Institute
- Mary Bird Perkins Cancer Center
- Mayo Clinic
- med fusion (Acquired by Quest Diagnostics)
- Medable
- MedAvante-ProPhase (Acquired by WCG)
- MEDEX
- Median Technologies
- Medicor Research
- Medicus Alliance
- Medicus Health Partners
- Medidata
- Melanoma Research Alliance
- MENE Health Group
- Merck
- Merck Global Health Innovation Fund (GHI)
- Metrics Champion Consortium (MCC) (Acquired by WCG)
- Mitsui
- MMG
- Molecular Templates
- Montserrat Day Hospitals
- MPM Capital
- MPR
- MTIP
- Muscular Dystrophy Association (MDA)
- National Cancer Center
- National Institute of Clinical Research (NICR)
- National Taiwan University Hospital (NTUH)
- NeoGenomics
- Newton Clinical Research
- NextPhase Research
- Nomad Life Sciences
- North Estonia Medical Centre
- Novotech
- nRollmed
- Nucleon Therapeutics
- O4 Research
- Oaxaca Site Management Organization (OSMO)
- Octopus Investments
- Octopus Ventures
- Okogen
- OneOncology
- Optimum CRO
- Ora
- Oracle
- orphan reach
- Orphanos
- Ospedale San Raffaele
- P3 Research
- Panthera
- Parallel 6 (Acquired by PRA Health Sciences)
- Parexel
- PAS Research
- PatientPoint
- Peachtree
- Penta ID Innovation
- Pepgra
- Pfizer
- Pharmatech
- Pharm-Olam
- phaware
- Physicians Research Group (PRG)
- Plexus Research
- Polaris Biopharma Consulting
- PPC
- PPD
- Prabhans Clinical Services
- Praxis
- Precision for Medicine
- Precision Health
- Prime Site
- Prodia
- Protocol First
- ProTrials Research
- Prudentia
- Psilera
- Puerto Rico Consortium for Clinical Investigation (PRCCI)
- Pulse Clinical Research
- Pusan National University Hospital (PNUH)
- PWNHealth
- QAscent Research Solutions
- QPS
- Quad-C Management
- Quanticate
- Quantime World
- Quest Diagnostics
- Quintessential Solutions
- Ravek
- RealTime Software Solutions
- Red Maple Trials
- RemediumOne
- Research Trials Group
- RESolutions
- Reumalab
- Revive Therapeutics
- Richmond Behavioral Associates (RBA)
- Rock Springs Capital
- Rutherford Health plc
- S4 Research
- Sabre Partners
- Samahitha Research Solutions
- Sandia Clinical Research
- Sanjeevani
- Sanofi
- Santa Maria Gastroenterology
- Scandinavian CRO
- S-Clinical
- SDS Clinical
- Sequoia Capital
- SGS Life Science Services
- Shanghai Shoujia Medical Clinical Research
- SiChaGi Medical Solutions
- SIGAL SMS
- Signify Health
- SitePartner
- Skin Research Institute of Singapore (SRIS)
- Skylight Health
- Smedvig Capital
- SMO - DRA. MARISA VICO
- SMO Clinical Research (SMO-India)
- SMO ClinPlus
- SMO UCT
- SMOconnect
- Smooth Drug Development
- SMO-Pharmina
- Society for Clinical Research Sites
- Solutions OP
- Somaya Research and Health Services
- SoMex Research & Health Organisation
- Sonic Clinical Trials
- Spectral Medical
- Spectrum Clinical Research
- Spero Oncology (Acquired by Veristat)
- SPRI Ukraine
- Springhill Fund
- SQN Clinical
- Statistics Collaborative
- Superstring Capital
- Surescripts
- Syncretic Clinical Research Services
- Syneos Health
- Syntax
- Synteract
- Syreon
- Takeda Pharmaceutical
- Terveystalo
- TFS
- Association of Clinical Research Professionals (ACRP)
- The Buffalo-Niagara Clinical Alliance (BNCA)
- The Clinical Trial Company (TCTC) (Acquired by Veristat)
- The Clinic'les
- THREAD
- ThreeWire
- Tigermed
- Tiziana Life Sciences
- Topstone Research
- Total Clinical Trial Management
- Translational Research in Oncology (TRIO)
- Trial Management Group (TMG)
- Trialbee
- TrialSpark
- Trifecta (acquired by WCG)
- TriNetX
- Triumph Research Intelligence (TRI)
- Triumpharma
- United States Department of Defense (DOD)
- uMotif
- Unicorn Protego Site Management Organization (UP SMO)
- United BioSource (UBC)
- University of Yamanshi
- Urgent Care Clinical Trials
- Vector Oncology
- Veeda
- Veeva Systems
- VeraSci
- Veristat
- Vicore Pharma
- Vigilare International
- Viomedo
- Virgo
- Walter and Eliza Hall Institute of Medical Research (WEHI)
- WCCT Global
- WCG
- WCG Avoca
- WCG PharmaSeek
- WindRose Health Investors
- Worldwide Clinical Trials
- WuXi Clinical (a WuXi AppTec Company)
- Xcene Research
- Xylem
- Zagvo Portal
- ZARTA LIFE
- Zosano Pharma2-BBB Medicines
Methodology
LOADING...
